Results 161 to 170 of about 8,224,245 (384)

Kinetic Evidence for Multiple Binding Sites on Phosphofructokinase

, 1966
Oliver H. Lowry, Janet V. Passonneau
openalex   +1 more source

Slow GDP Dissociation from the guanyl nucleotide‐binding site of turkey erythrocyte membranes as the limiting step in the activation of adenylate cyclase by β‐adrenergic agonists [PDF]

, 1979
Stéphane Swillens, M. Juvent, Jacques E. Dumont   +2 more
openalex   +1 more source

MatInspector and beyond: promoter analysis based on transcription factor binding sites

Bioinform., 2005
Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T, Kerstin Cartharius   +9 more
semanticscholar   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Enkephalin analogs. Introduction of stereochemical constraints, metal binding sites and fluorescent groups [PDF]

, 1979
Ramakrishnan Nagaraj, T.S. Sudha, Shri Shivaji, P. Balaram   +3 more
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

RNA of the small subunit of the Escherichia coli ribosome With additional protein binding sites Characterization of the structure by electron micro [PDF]

, 1977
Heinz‐Kurt Hochkeppel, Julian Gordon, Christine Brack   +2 more
openalex   +1 more source

The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.

Proceedings of the National Academy of Sciences of the United States of America, 1974
J. Shine, L. Dalgarno
semanticscholar   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Isolation of antibodies specific for the carbohydrate binding site of Concanavalin A [PDF]

, 1979
Raquel A. Calderón, F. Córdoba
openalex   +1 more source